Latest "Penguin group (usa)" News Stories

00:22 EDT 23rd September 2018 | BioPortfolio

Here are the most relevant search results for "Penguin group (usa)" found in our extensive news archives from over 250 global news sources.

More Information about Penguin group (usa) on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Penguin group (usa) for you to read. Along with our medical data and news we also list Penguin group (usa) Clinical Trials, which are updated daily. BioPortfolio also has a large database of Penguin group (usa) Companies for you to search.

Showing "Penguin group" News Articles 1–25 of 7,800+

Saturday 22nd September 2018

Late-Breaking Clinical Study Results Demonstrate Exceptional Safety and Efficacy Outcomes for Resolute Onyx(TM) DES

TCT18: BIONYX Study Shows Strong Performance with Durable Polymer Resolute Onyx DES in Head-to-Head Comparison with Biodegradable Polymer DES DUBLIN and SAN DIEGO - September 22, 2018 - Investigators today unveiled new clinical data from the physician-initiated BIONYX study, representing the first all-comers analysis in nearly 2,500 patients comparing the safety and efficacy of th...

[Articles] Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt–chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-b

The Resolute Onyx stent was non-inferior to Orsiro for a combined safety and efficacy endpoint at 1-year follow-up in allcomers. The low event rate in both groups suggests that both stents are safe, and the very low rate of stent thrombosis in the Resolute Onyx group warrants further clinical investigation.

Sosei, Allergan voluntarily suspend clinical development of HTL0018318

Sosei Group Corporation, the world leader in GPCR medicine design and development, announces that the Company and Allergan, its license partner for HTL0018318, have decided to voluntarily suspend clinical development

PBM Trade Group Taps Medical Device Lobbyist Scott As CEO

AdvaMed Chief Advocacy Officer JC Scott will take the reins at PCMA in mid-October.    

Stemgent Inc Strategic SWOT Analysis Review [Report Updated: 08052018] Prices from USD $125

Stemgent Inc Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your business by ena...

Friday 21st September 2018

Busabout Launches New Small Group Adventures in Europe with 2019-20 Collection

BOCA RATON, Fla., Sept. 21, 2018 /PRNewswire/ -- Packed with past guests' own photographs and testimonials, Busabout's new 2019/20 Europe brochure makes it easier than Read more...

SHAREHOLDER ALERT: Monteverde Associates PC Announces An Investigation Of The Navigators Group, ...

NEW YORK, Sept. 21, 2018 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Read more...

Most Popular NEJM Group Feature This Week: Coffee and the State of the Hospital

Here's the most clicked-on item we featured from NEJM Group this week, in case you missed it the first time around: You can tell...

Accsys Technologies (AXS) - Accoya volume rising, more capacity on stream

Edison Investment Research - General Industrials - Accsys Technologies: AGM comments point to operational progress at Arnhem and an on-track construction schedule for the new Tricoya facility at Hull. Accsys has set out a clear development plan for the group; while we are not placing undue weight on a short trading period, we are encouraged to see that growing revenues and production volumes have ...

Gov. Henry McMaster and UnitedHealth Group Announce $500,000 Donation to One SC Fund in Support of South Carolina Residents Affected by Hurricane Florence

South Carolina Gov. Henry McMaster joined UnitedHealth Group to announce a $500,000 donation to the state’s One SC Fund to help residents of South Carolina recover and rebuild from Hurricane Florence. This press release features multimedia. View the full release here: South Carolina Gov. Henry McMaster ...

Spray-On Antennas Could Unlock Potential of Smart, Connected Technology

NewsThe group reports on a method for spraying invisibly thin antennas, made from a type of two-dimensional, metallic material called MXene.Cont

Hitachi's First Dedicated Compact Proton Therapy System to be Supplied to Tokushukai Medical Group

Hitachi, Ltd. (TSE: 6501, “Hitachi”) announced today that it has received an order for the compact proton therapy system from Tokushukai Medical Group, and the system will be installed at Shonan Kamakura Advanced Medical Center, which is planned to be built near Shonan Kamakura General Hospital.

Grade Group Better Than Gleason Score for Predicting Prostate Cancer Outcomes

Reuters Health Information

Composition of Terveystalo Plc's Shareholders' Nomination Board

Terveystalo Plc Stock Exchange release 21 September 2018 at 17:30 p.m. EEST   The Shareholders' Nomination Board of Terveystalo Plc comprises the representatives of the four largest shareholders of the company as at 3 September 2018 and, in addition, the Chairman of the Board of Directors. The duties of the Nomination Board include the search, preparation and presentation of ...

Group Files Complaint Against Airline Lab Animal Ban

NewsFour major airlines are facing a legal challenge in an effort to reverse the ban on transporting animals used for biomedical research.

Joseph Ravenell, a physician-scientist, notes that black men are most likely group to get colon cancer and die from it in US. Screening saves lives, but isn't getting done. Can improve by spreading word in trusted community hubs, like barbershops. #BidenC

Joseph Ravenell, a physician-scientist, notes that black men are most likely group to get colon cancer and die from it in US. Screening saves lives, but isn't getting done. Can improve by spreading word in trusted community hubs, like barbershops. #BidenCancerSummit

Remedy Plan Therapeutics Named Winner of MTC’s Inaugural Start-Up Pitch Contest at Bio+Tech18

The Maryland Tech Council (MTC) concluded its Bio+Tech18 Conference yesterday in Baltimore with the announcement of

Enigma Biomedical and Invicro Sign a Memorandum of Understanding to Co-Develop Synaptic Density Biomarker Imaging

Enigma Biomedical Group (EBG) today announced a collaboration agreement with Invicro, a Konica Minolta Company and a leading provider of imaging services and software for research and drug development, to cooperate in the development of Synaptic Density Biomarker Imaging (“SDI”). SDI promises to provide an important new tool in understanding neurodegen...

Spark Therapeutics Announces Positive CHMP Opinion for One-time Gene Therapy LUXTURNA® (voretigene neparvovec) in the European Union

LUXTURNA would be first gene therapy for a genetic disease approved in both U.S. and EU LUXTURNA would be first and only gene therapy approved in EU to treat patients with vision loss due to inherited retinal dystrophy caused by confirmed biallelic RPE65 mutations and who have sufficient viable retinal cells, a condition leading to total blindness in most patients Positive opinion based o...

Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib

– Opinion Based on Pivotal Phase 2 ALTA Trial, in which ALUNBRIG Demonstrated an Objective Response Rate of 56% and Longest Reported Median Progression-Free Survival of 16.7 months in the Post-Crizotinib Setting – Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medi...

Alzheimer's, Related Dementias Predicted to Double by 2060

A new study from the CDC is the first to examine expected increases in Alzheimer's disease and related dementias in older Americans by racial and ethnic group. Medscape Medical News

Hesperos, Inc. Among GrowFL 2018 Florida Companies to Watch

Hesperos, Inc. has announced that it has been named one of the 50 statewide companies expected to see significant growth over the next several years by GrowFL. The 50 companies were selected from more than 500 nominees for Florida Companies to WatchSM, a statewide program managed by economic development group GrowFL, in association with the Edward Lowe Fou...

Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with Advanced Malignant Neuroendocrine Tumors at Annual Meeting of the Chinese Society of Clinical Oncology

SUZHOU, China, Sept. 21, 2018 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, today presented clinical trial data from a phase Ib clinical trial (NCT02937116) that treated patients with neuroendocrine tumors (NET) who have failed of standard therapy with single agent sintilimab, a fully hu...

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

GlaxoSmithKline plc and Innoviva, Inc. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion today supporting the use of Trelegy Ellipta in a broader group of patients with moderate to severe chronic obstructive pulmonary disease and that labeling, if approved, will be updated to further reflect its effect on exacerbations of CO...

SanBio: Supplementary Information to the Notice Regarding an Equity and Business Alliance Between Five Companies for Joint Research on the Appropriate Use, Adoption, and Stable Distribution of Regenerative Cell Medicine SB623

SanBio Co., Ltd. (representative: Keita Mori, headquarters: Chuo-ku, Tokyo; hereinafter SanBio) has agreed to enter into an equity and business alliance with CareNet, Inc. (representative: Katsuhiro Fujii, headquarters: Chiyoda-ku, Tokyo; hereinafter CareNet), Medical Incubator Japan K.K. (representative: Jun Katsura, headquarters: Minato-ku, Tokyo; herein...

Quick Search


News Quicklinks